2026-06-04

FDA approves drug (AbbVie) - new revenue stream

FDA approves drug (AbbVie) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

FDA approves drug (PFIZER) - new revenue stream

Beat consensus by 14.4% - EPS $-0.06 vs $-0.0701 estimate

Q1-2027: Beat consensus by 13.9% - EPS $1.56 vs $1.3691 estimate

Q1-2026: Beat consensus by 52.3% - EPS $0.63 vs $0.4136 estimate

Q1-2026: Beat consensus by 13.8% - EPS $0.26 vs $0.2285 estimate

Q1-2027: Beat consensus by 16.0% - EPS $-0.06 vs $-0.0714 estimate

Q1-2026: Beat consensus by 13.1% - EPS $-0.81 vs $-0.9321 estimate

Q4-2025: Beat consensus by 14.8% - EPS $-0.83 vs $-0.9739 estimate

Q3-2025: Beat consensus by 10.0% - EPS $-0.92 vs $-1.0219 estimate

Q2-2025: Beat consensus by 5.6% - EPS $-0.98 vs $-1.0382 estimate

Q4-2024: Beat consensus by 9.7% - EPS $-0.82 vs $-0.9078 estimate

Q3-2024: Beat consensus by 21.0% - EPS $-0.85 vs $-1.0761 estimate

Beat consensus by 21.6% - EPS $-1 vs $-1.275 estimate

Q4-2025: Missed consensus by 6.4% - EPS $-5.08 vs $-4.7761 estimate

Q1-2026: Beat consensus by 5.0% - EPS $1.25 vs $1.1903 estimate

Q2-2025: Missed consensus by 47.5% - EPS $0.6 vs $1.1424 estimate

Q4-2025: Beat consensus by 33.7% - EPS $1.28 vs $0.9574 estimate

Q3-2025: Beat consensus by 20.5% - EPS $0.97 vs $0.8051 estimate

Q2-2025: Missed consensus by 14.8% - EPS $-0.17 vs $-0.1481 estimate

Q1-2026: Missed consensus by 436.4% - EPS $-0.84 vs $-0.1566 estimate

Q3-2025: Beat consensus by 1070.8% - EPS $1.03 vs $-0.1061 estimate

Q4-2025: Missed consensus by 106.5% - EPS $-0.24 vs $-0.1162 estimate

Q3-2025: Missed consensus by 5.8% - EPS $1.22 vs $1.2945 estimate

Q1-2026: Beat consensus by 6.9% - EPS $1.49 vs $1.3938 estimate

Q4-2025: Beat consensus by 32.9% - EPS $1.43 vs $1.0764 estimate

Q2-2025: Missed consensus by 33.4% - EPS $0.95 vs $1.4257 estimate

Q3-2025: Missed consensus by 9.2% - EPS $0.33 vs $0.3636 estimate

Q4-2025: Missed consensus by 114.1% - EPS $-0.02 vs $0.1414 estimate

Q2-2025: Beat consensus by 16.5% - EPS $0.4 vs $0.3434 estimate

Q4-2022: Beat consensus by 8.4% - EPS $-0.635 vs $-0.6936 estimate

Q3-2023: Missed consensus by 46.2% - EPS $-0.44 vs $-0.3009 estimate

Q1-2023: Missed consensus by 36.7% - EPS $-0.76 vs $-0.5559 estimate

Missed consensus by 104.8% - EPS $-0.94 vs $-0.459 estimate

Q3-2025: Beat consensus by 8.7% - EPS $-0.66 vs $-0.7227 estimate

Q1-2026: Beat consensus by 19.1% - EPS $-0.45 vs $-0.5565 estimate

Q2-2025: Beat consensus by 11.8% - EPS $-0.77 vs $-0.8731 estimate

Q4-2025: Beat consensus by 10.7% - EPS $-0.65 vs $-0.7279 estimate

Q4-2025: Missed consensus by 20.7% - EPS $2.27 vs $2.8608 estimate

Beat consensus by 12.2% - EPS $-1.2 vs $-1.366 estimate

Q2-2025: Missed consensus by 446.1% - EPS $-0.45 vs $-0.0824 estimate

Q2-2026: Beat consensus by 16.2% - EPS $1.08 vs $0.9295 estimate

Q1-2027: Beat consensus by 10.1% - EPS $1.24 vs $1.1262 estimate

Q3-2026: Beat consensus by 7.7% - EPS $1.01 vs $0.9376 estimate

Q2-2025: Missed consensus by 34.0% - EPS $0.08 vs $0.1212 estimate

Q4-2025: Missed consensus by 12.9% - EPS $0.11 vs $0.1263 estimate

Q3-2025: Beat consensus by 5.6% - EPS $0.16 vs $0.1515 estimate

Beat consensus by 19.8% - EPS $0.86 vs $0.718 estimate

Q3-2025: Beat consensus by 44.0% - EPS $-0.91 vs $-1.6261 estimate

Q1-2026: Beat consensus by 11.8% - EPS $-0.82 vs $-0.9292 estimate

Missed consensus by 42.4% - EPS $-2.87 vs $-2.015 estimate

Q4-2025: Missed consensus by 460.9% - EPS $-5.41 vs $-0.9646 estimate

Beat consensus by 5.4% - EPS $3.67 vs $3.481 estimate

Q2-2025: Beat consensus by 16.6% - EPS $-0.71 vs $-0.8517 estimate

Q4-2025: Missed consensus by 30.1% - EPS $-0.71 vs $-0.5457 estimate

Missed consensus by 37.9% - EPS $-0.75 vs $-0.544 estimate

Q4-2025: Beat consensus by 77.3% - EPS $-2.06 vs $-9.0576 estimate

Missed consensus by 14.9% - EPS $-20.4 vs $-17.748 estimate

Q1-2026: Missed consensus by 32.7% - EPS $-1.99 vs $-1.4994 estimate

Q2-2025: Beat consensus by 58.9% - EPS $-20.04 vs $-48.7152 estimate

Q2-2025: Beat consensus by 20.9% - EPS $0.59 vs $0.4882 estimate

Q1-2026: Beat consensus by 137.0% - EPS $0.75 vs $0.3165 estimate

Q3-2025: Missed consensus by 11.9% - EPS $0.54 vs $0.6127 estimate

Q4-2025: Missed consensus by 36.8% - EPS $0.3 vs $0.4747 estimate

Q2-2025: Beat consensus by 236.9% - EPS $0.19 vs $0.0564 estimate

Beat consensus by 10.2% - EPS $0.78 vs $0.708 estimate

Q1-2026: Beat consensus by 14.2% - EPS $0.77 vs $0.6745 estimate

Beat consensus by 38.5% - EPS $0.55 vs $0.397 estimate

Q3-2025: Beat consensus by 13.2% - EPS $1.68 vs $1.4846 estimate

Q2-2025: Beat consensus by 30.1% - EPS $2.28 vs $1.7529 estimate

Q1-2026: Missed consensus by 46.1% - EPS $0.68 vs $1.2611 estimate

Q4-2025: Beat consensus by 25.2% - EPS $1.81 vs $1.4454 estimate

Q1-2026: Beat consensus by 24.0% - EPS $5.25 vs $4.2331 estimate

Q4-2025: Beat consensus by 15.7% - EPS $5.79 vs $5.0057 estimate

Q3-2025: Beat consensus by 19.5% - EPS $5.09 vs $4.2596 estimate

Q3-2025: Beat consensus by 8.2% - EPS $1.75 vs $1.6177 estimate

Q2-2025: Beat consensus by 9.1% - EPS $1.57 vs $1.4389 estimate

Q1-2027: Beat consensus by 29.2% - EPS $-0.39 vs $-0.5508 estimate

Beat consensus by 14.3% - EPS $3.45 vs $3.0175 estimate

Beat consensus by 87.3% - EPS $1.9364 vs $1.0336 estimate

Missed consensus by 233.9% - EPS $-3.36 vs $-1.0064 estimate

Q4-2025: Beat consensus by 8.3% - EPS $1.02 vs $0.9418 estimate

Q2-2026: Missed consensus by 22.4% - EPS $0.8 vs $1.0305 estimate

Q1-2026: Beat consensus by 11.7% - EPS $1.06 vs $0.9486 estimate

Q1-2026: Missed consensus by 231.8% - EPS $-0.39 vs $0.2958 estimate

Q2-2025: Missed consensus by 343.8% - EPS $-1.38 vs $0.5661 estimate

Q4-2025: Beat consensus by 220.4% - EPS $6.34 vs $1.9788 estimate

Q3-2025: Missed consensus by 155.7% - EPS $-0.52 vs $0.9333 estimate

Q2-2024: Beat consensus by 74.1% - EPS $-1.14311 vs $-4.4064 estimate

Beat consensus by 77.0% - EPS $-0.223 vs $-0.969 estimate

Beat consensus by 52.4% - EPS $-0.34 vs $-0.714 estimate

Q4-2025: Beat consensus by 9.1% - EPS $0.69 vs $0.6324 estimate

Q3-2025: Missed consensus by 7.5% - EPS $0.42 vs $0.4539 estimate

Q1-2026: Missed consensus by 26.6% - EPS $0.52 vs $0.7089 estimate

Q4-2025: Beat consensus by 21.8% - EPS $0.77 vs $0.6324 estimate

Q2-2025: Beat consensus by 120.1% - EPS $0.55 vs $0.2499 estimate

Beat consensus by 12.2% - EPS $1.03 vs $0.918 estimate

Q4-2025: Beat consensus by 90.0% - EPS $0.94 vs $0.4947 estimate

Q1-2026: Missed consensus by 37.3% - EPS $0.24 vs $0.3825 estimate

Q3-2025: Beat consensus by 12.6% - EPS $-0.45 vs $-0.5151 estimate

Q4-2025: Beat consensus by 17.8% - EPS $-0.38 vs $-0.4624 estimate

Beat consensus by 10.8% - EPS $-1.09 vs $-1.222 estimate

Beat consensus by 15.7% - EPS $-0.99 vs $-1.175 estimate

Q1-2026: Missed consensus by 46.6% - EPS $-1.11 vs $-0.7574 estimate

Beat consensus by 10.4% - EPS $-1.14 vs $-1.273 estimate

Q2-2026: Beat consensus by 6.4% - EPS $0.91 vs $0.8553 estimate

Beat consensus by 6.4% - EPS $0.82 vs $0.771 estimate

Q4-2025: Missed consensus by 56.2% - EPS $-0.27 vs $-0.1729 estimate

Q2-2025: Missed consensus by 61.0% - EPS $-0.18 vs $-0.1118 estimate

Q3-2025: Missed consensus by 49.4% - EPS $-0.2 vs $-0.1339 estimate

Q4-2025: Beat consensus by 24.5% - EPS $0.13 vs $0.1044 estimate

Missed consensus by 16.7% - EPS $0.08 vs $0.096 estimate

Q3-2025: Missed consensus by 84.3% - EPS $0.02 vs $0.1275 estimate

Q4-2025: Beat consensus by 100.5% - EPS $0.15 vs $0.0748 estimate

Q1-2026: Missed consensus by 477.3% - EPS $-0.53 vs $-0.0918 estimate

Q2-2025: Beat consensus by 97.5% - EPS $0.45 vs $0.2278 estimate

Q1-2026: Beat consensus by 11.6% - EPS $0.36 vs $0.3227 estimate

Q3-2025: Beat consensus by 64.0% - EPS $0.71 vs $0.4328 estimate

Q2-2025: Beat consensus by 33.9% - EPS $0.54 vs $0.4033 estimate

Q4-2025: Beat consensus by 35.6% - EPS $0.45 vs $0.3318 estimate

Q3-2025: Beat consensus by 10.4% - EPS $0.48 vs $0.4348 estimate

Missed consensus by 71.8% - EPS $0.05 vs $0.177 estimate

Q2-2025: Beat consensus by 25.7% - EPS $0.53 vs $0.4217 estimate

Q1-2027: Missed consensus by 65.3% - EPS $0.03 vs $0.0864 estimate

Q1-2026: EPS $0.06 vs $0.0354 estimate, +0.02 on a near-zero consensus

Q3-2025: EPS $-0.17 vs $-0.0498 estimate, -0.12 on a near-zero consensus

Q1-2026: EPS $0.00 vs $-0.0371 estimate, +0.04 on a near-zero consensus

Q4-2025: EPS $0.04 vs $-0.0062 estimate, +0.05 on a near-zero consensus

Q1-2026: EPS $0.1353 vs $-0.0408 estimate, +0.18 on a near-zero consensus

Q1-2027: EPS $0.01 vs $0.0157 estimate, -0.01 on a near-zero consensus

BTC ETF outflow of $4150M - institutional selling

ETH ETF outflow of $1242M - institutional selling

ETH open interest -62.4% - OI collapse

BTC open interest -42.9% - OI collapse

SOL open interest -22.0% - OI collapse

ETH ETF outflow of $1242M - institutional selling

BTC ETF outflow of $4150M - institutional selling

SOL open interest +234.2% - OI surge

ETH open interest +203.0% - OI surge

BTC open interest +184.0% - OI surge

SOL open interest -28.0% - OI collapse

ETH open interest +208.9% - OI surge

BTC open interest -44.3% - OI collapse

BTC open interest -36.0% - OI collapse

ETH open interest -65.0% - OI collapse

SOL open interest -31.8% - OI collapse

SOL funding rate -0.0233% - SHORT SQUEEZE SETUP

ETH DEX volume/liquidity ratio elevated (0.95x) - strong on-chain trading activity

SOL DEX volume/liquidity ratio elevated (1.32x) - strong on-chain trading activity

SOL funding rate -0.0212% - SHORT SQUEEZE SETUP

OSINT: Ukrainian Drone Strikes Russian Patrol Boat Guarding Crimean Bridge

OSINT: US oil stocks hit 2004 low as Trump‑Iran tensions could drive prices to $200

Gold +1.59% - significant rally

Oil -3.15% - significant selloff

Gold +1.66% - significant rally

Oil -3.48% - significant selloff

Gold +1.37% - significant rally

Oil -1.60% - significant selloff

Gold +1.23% - significant rally

GOLD RSI 27.6 - oversold (crossed below 30)

Oil +1.83% - significant rally

DXY -0.31% - dollar weakness signal